Acta Ophthalmologica, ISSN 1755-375X, 09/2017, Volume 95, Issue S259, p. n/a
Purpose To evaluate predictors of visual outcome in a series of patients treated for postoperative endophthalmitis (PE) and analyze the role of therapeutic...
Endophthalmitis | Analysis | Eye | Statistical analysis | Antibiotics | Visual acuity | Diagnosis | Regression analysis | Patients | Significance | Acuity
Endophthalmitis | Analysis | Eye | Statistical analysis | Antibiotics | Visual acuity | Diagnosis | Regression analysis | Patients | Significance | Acuity
Journal Article
Acta Ophthalmologica, ISSN 1755-375X, 10/2016, Volume 94, Issue S256, p. n/a
Purpose To determine the relation between the use of silicone oil (SO) as an intraocular tamponade and the incidence of unexplained loss of visual acuity....
Silicones | Hypertension | Toxicity | Retina | Visual acuity | Patients | Incidence | Acuity | Tamponade | Oil | Vision | Surgery | Eye (anatomy) | Intraocular pressure
Silicones | Hypertension | Toxicity | Retina | Visual acuity | Patients | Incidence | Acuity | Tamponade | Oil | Vision | Surgery | Eye (anatomy) | Intraocular pressure
Journal Article
Ophthalmic Genetics, ISSN 1381-6810, 11/2019, pp. 1 - 4
Journal Article
Journal of Ophthalmology, ISSN 2090-004X, 10/2019, Volume 2019, pp. 1 - 6
The microbiological profile of infectious keratitis has shown great differences across the world. Due to the continuous shifting trends in microbiological...
Journal Article
Acta Ophthalmologica, ISSN 1755-375X, 10/2015, Volume 93, p. n/a
Purpose To compare the impact of early versus late complete vitrectomy in the management of acute postoperative endophthalmitis (PE). Methods Retrospective...
Journal Article
International Journal of Electrical Power and Energy Systems, ISSN 0142-0615, 06/2019, Volume 108, pp. 432 - 444
Current approaches for risk management in energy market participation mostly refer to portfolio optimization for long-term planning, and stochastic approaches...
Perfect competition | Strategic negotiations | Electricity markets | Multi-agent simulation | Sectorial data | Artificial neural network | Risk management | BEHAVIOR | NEGOTIATION | SIMULATION | ENGINEERING, ELECTRICAL & ELECTRONIC | RENEWABLE ENERGY | FRAMEWORK | OPTIMIZATION | GENERATION | Case studies | Investment analysis | Information management | Neural networks
Perfect competition | Strategic negotiations | Electricity markets | Multi-agent simulation | Sectorial data | Artificial neural network | Risk management | BEHAVIOR | NEGOTIATION | SIMULATION | ENGINEERING, ELECTRICAL & ELECTRONIC | RENEWABLE ENERGY | FRAMEWORK | OPTIMIZATION | GENERATION | Case studies | Investment analysis | Information management | Neural networks
Journal Article
Acta Ophthalmologica, ISSN 1755-375X, 09/2012, Volume 90
Purpose The source of endogenous catecholamines that activate corneal adrenoceptors is largely unknown. Since the cornea is a densely innervated tissue we...
Phenols | Noradrenaline
Phenols | Noradrenaline
Journal Article
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, ISSN 0886-3350, 07/2010, Volume 36, Issue 7, pp. 1242 - 1243
Journal Article
Experimental Eye Research, ISSN 0014-4835, 03/2018, Volume 168, pp. 107 - 114
We set out to demonstrate that the major source of corneal catecholamines is its neuronal release from intrinsic sympathetic nerves rather than circulating or...
Human | Cornea | Sympathetic nerves | Rabbit | Neuronal topography | Noradrenaline origin | Concentration gradient | DOPAMINE-BETA-HYDROXYLASE | RELEASE | FAILURE | ADRENERGIC-NERVES | EYE | TRANSPORT | SYMPATHETIC INNERVATION | OPHTHALMOLOGY | AGE
Human | Cornea | Sympathetic nerves | Rabbit | Neuronal topography | Noradrenaline origin | Concentration gradient | DOPAMINE-BETA-HYDROXYLASE | RELEASE | FAILURE | ADRENERGIC-NERVES | EYE | TRANSPORT | SYMPATHETIC INNERVATION | OPHTHALMOLOGY | AGE
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 09/2012, Volume 367, Issue 10, pp. e14 - E14
A 34-year-old man presented to the emergency department with 3 days of photophobia, tearing, and the sensation of having a foreign body in his right eye. A...
MEDICINE, GENERAL & INTERNAL | Cornea | Infections | Dendrites | Herpes viruses
MEDICINE, GENERAL & INTERNAL | Cornea | Infections | Dendrites | Herpes viruses
Journal Article
Experimental Eye Research, ISSN 0014-4835, 09/2018, Volume 174, pp. 121 - 132
Having established a main neuronal origin for noradrenaline (NA) in the cornea, we set out to study the physiologic determinants of its release and to...
Human | Cornea | Sympathetic nerves | Rabbit | Neuronal topography | Adrenergic mechanisms | Fractional rate of loss | Electrically-evoked overflow | Regulation of noradrenaline release | Alpha-2 adrenoceptors | NERVES | DOPAMINE-BETA-HYDROXYLASE | EPITHELIAL-CELLS | VIMENTIN | NEURONS | OPHTHALMOLOGY | MICE | RECEPTORS | EXPRESSION | WOUND REPAIR | Monoclonal antibodies | Phenols | Neurons | Laws, regulations and rules | Noradrenaline | Analysis
Human | Cornea | Sympathetic nerves | Rabbit | Neuronal topography | Adrenergic mechanisms | Fractional rate of loss | Electrically-evoked overflow | Regulation of noradrenaline release | Alpha-2 adrenoceptors | NERVES | DOPAMINE-BETA-HYDROXYLASE | EPITHELIAL-CELLS | VIMENTIN | NEURONS | OPHTHALMOLOGY | MICE | RECEPTORS | EXPRESSION | WOUND REPAIR | Monoclonal antibodies | Phenols | Neurons | Laws, regulations and rules | Noradrenaline | Analysis
Journal Article
Graefe's Archive for Clinical and Experimental Ophthalmology, ISSN 0721-832X, 1/2018, Volume 256, Issue 1, pp. 83 - 89
To evaluate functional and anatomical outcomes after aflibercept in patients with diabetic macular edema (DME) with poor response to bevacizumab.We...
Refractory | Ophthalmology | Medicine & Public Health | Aflibercept | Diabetic macular edema | Bevacizumab | RANIBIZUMAB AND/OR BEVACIZUMAB | EYES | INTRAVITREAL RANIBIZUMAB | THERAPY | INJECTION | OPHTHALMOLOGY | THICKNESS | Dropsy | Edema | Diabetics | Eye | Diabetes mellitus | Diabetes | Variation | Acuity
Refractory | Ophthalmology | Medicine & Public Health | Aflibercept | Diabetic macular edema | Bevacizumab | RANIBIZUMAB AND/OR BEVACIZUMAB | EYES | INTRAVITREAL RANIBIZUMAB | THERAPY | INJECTION | OPHTHALMOLOGY | THICKNESS | Dropsy | Edema | Diabetics | Eye | Diabetes mellitus | Diabetes | Variation | Acuity
Journal Article
Retina, ISSN 0275-004X, 2017, Volume 37, Issue 3, pp. 529 - 535
Purpose: To evaluate choroidal morphology and thickness at the posterior pole of individuals affected by multisystemic autoimmune diseases and without known...
Lupus | Choroidal thickness | Hydroxychloroquine | Autoimmune diseases | Rheumatoid arthritis | autoimmune diseases | RHEUMATOID-ARTHRITIS | DIABETIC-RETINOPATHY | INDOCYANINE GREEN | SYSTEMIC-LUPUS-ERYTHEMATOSUS | MANAGEMENT | OPTICAL COHERENCE TOMOGRAPHY | POSTERIOR POLE | CHOROIDOPATHY | lupus | rheumatoid arthritis | CATARACT-SURGERY | CENTRAL SEROUS CHORIORETINOPATHY | hydroxychloroquine | OPHTHALMOLOGY | choroidal thickness | Hydroxychloroquine - therapeutic use | Choroid - diagnostic imaging | Glucocorticoids - therapeutic use | Lupus Erythematosus, Systemic - complications | Cross-Sectional Studies | Tomography, Optical Coherence | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Autoimmune Diseases - complications | Organ Size | Male | Healthy Volunteers | Arthritis, Rheumatoid - complications | Arthritis, Rheumatoid - drug therapy | Lupus Erythematosus, Systemic - drug therapy | Adult | Female | Retrospective Studies | Choroid - pathology | Autoimmune Diseases - drug therapy | Antirheumatic Agents - therapeutic use
Lupus | Choroidal thickness | Hydroxychloroquine | Autoimmune diseases | Rheumatoid arthritis | autoimmune diseases | RHEUMATOID-ARTHRITIS | DIABETIC-RETINOPATHY | INDOCYANINE GREEN | SYSTEMIC-LUPUS-ERYTHEMATOSUS | MANAGEMENT | OPTICAL COHERENCE TOMOGRAPHY | POSTERIOR POLE | CHOROIDOPATHY | lupus | rheumatoid arthritis | CATARACT-SURGERY | CENTRAL SEROUS CHORIORETINOPATHY | hydroxychloroquine | OPHTHALMOLOGY | choroidal thickness | Hydroxychloroquine - therapeutic use | Choroid - diagnostic imaging | Glucocorticoids - therapeutic use | Lupus Erythematosus, Systemic - complications | Cross-Sectional Studies | Tomography, Optical Coherence | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Autoimmune Diseases - complications | Organ Size | Male | Healthy Volunteers | Arthritis, Rheumatoid - complications | Arthritis, Rheumatoid - drug therapy | Lupus Erythematosus, Systemic - drug therapy | Adult | Female | Retrospective Studies | Choroid - pathology | Autoimmune Diseases - drug therapy | Antirheumatic Agents - therapeutic use
Journal Article
Acta Ophthalmologica, ISSN 1755-375X, 10/2016, Volume 94, Issue S256, p. n/a
Purpose To evaluate the predictive factors of long‐term visual outcomes in neovascular age‐related macular degeneration (nAMD) treated with anti‐VEGF agents....
Macular degeneration | Diabetic retinopathy | Care and treatment | Analysis | Physiological aspects | Neovascularization | Vascular endothelial growth factor | Multivariate analysis | Age | Visual aspects | Retina | Visual acuity | Epithelium | Patients | Hemorrhage | Age related diseases | Retinal pigment epithelium | Vascularization | Acuity | Atrophy | Fibrosis | Retinal degeneration | Diagnosis
Macular degeneration | Diabetic retinopathy | Care and treatment | Analysis | Physiological aspects | Neovascularization | Vascular endothelial growth factor | Multivariate analysis | Age | Visual aspects | Retina | Visual acuity | Epithelium | Patients | Hemorrhage | Age related diseases | Retinal pigment epithelium | Vascularization | Acuity | Atrophy | Fibrosis | Retinal degeneration | Diagnosis
Journal Article
Investigative Ophthalmology and Visual Science, ISSN 0146-0404, 08/2017, Volume 58, Issue 10, pp. 4138 - 4142
PURPOSE. We investigate the prevalence of the Charles Bonnet syndrome (CBS) in patients with neovascular age-related macular degeneration (AMD) and analyze the...
Oral proton pump inhibitors | Charles Bonnet syndrome | Low vision | Visual hallucinations | Neovascular age-related macular degeneration | neovascular age-related macular degeneration | low vision | COMPLEX VISUAL HALLUCINATIONS | POPULATION | oral proton pump inhibitors | BONNET,CHARLES SYNDROME | DISEASE | OPHTHALMOLOGY | visual hallucinations | PREVALENCE | Proton Pump Inhibitors - adverse effects | Prevalence | Wet Macular Degeneration - complications | Humans | Middle Aged | Risk Factors | Hallucinations - chemically induced | Logistic Models | Male | Hallucinations - epidemiology | Hallucinations - etiology | Syndrome | Portugal - epidemiology | Aged, 80 and over | Female | Aged
Oral proton pump inhibitors | Charles Bonnet syndrome | Low vision | Visual hallucinations | Neovascular age-related macular degeneration | neovascular age-related macular degeneration | low vision | COMPLEX VISUAL HALLUCINATIONS | POPULATION | oral proton pump inhibitors | BONNET,CHARLES SYNDROME | DISEASE | OPHTHALMOLOGY | visual hallucinations | PREVALENCE | Proton Pump Inhibitors - adverse effects | Prevalence | Wet Macular Degeneration - complications | Humans | Middle Aged | Risk Factors | Hallucinations - chemically induced | Logistic Models | Male | Hallucinations - epidemiology | Hallucinations - etiology | Syndrome | Portugal - epidemiology | Aged, 80 and over | Female | Aged
Journal Article
Acta Ophthalmologica, ISSN 1755-375X, 10/2016, Volume 94, Issue S256, p. n/a
Purpose To evaluate macular functional changes using multifocal electroretinography and microperimetry after half‐dose photodynamic therapy with verteporfin...
Diabetic retinopathy | Care and treatment | Photochemotherapy | Analysis | Cancer | Electroretinography | Sensitivity | Sensitivity analysis | Photodynamic therapy | Correlation analysis | Retina | Charts | Event-related potentials | Eye (anatomy) | Patients | Structure-function relationships
Diabetic retinopathy | Care and treatment | Photochemotherapy | Analysis | Cancer | Electroretinography | Sensitivity | Sensitivity analysis | Photodynamic therapy | Correlation analysis | Retina | Charts | Event-related potentials | Eye (anatomy) | Patients | Structure-function relationships
Journal Article
Acta Ophthalmologica, ISSN 1755-375X, 10/2016, Volume 94, Issue S256, p. n/a
Purpose To analyze pre‐surgical macular hole (MH) angle measured by spectral domain optical coherence tomography (SD‐OCT) and its influence on anatomical and...
Surgery | Analysis | Multivariate analysis | Statistical analysis | Independent variables | Visual observation | Retina | Visual acuity | Regression analysis | Acuity | Eye | Optical Coherence Tomography | Mathematical analysis | Dependent variables | Eye (anatomy)
Surgery | Analysis | Multivariate analysis | Statistical analysis | Independent variables | Visual observation | Retina | Visual acuity | Regression analysis | Acuity | Eye | Optical Coherence Tomography | Mathematical analysis | Dependent variables | Eye (anatomy)
Journal Article
Ophthalmologica, ISSN 0030-3755, 06/2015, Volume 233, Issue 3-4, pp. 155 - 161
Purpose: To report the clinical outcomes of intravitreal aflibercept therapy in eyes with refractory and recurrent neovascular age-related macular degeneration...
Original Paper | Wet age-related macular degeneration | Choroidal neovascularization | Switch | Aflibercept | Ranibizumab | Bevacizumab | TACHYPHYLAXIS | PHOTODYNAMIC THERAPY | MACULAR DEGENERATION | DISEASE | TRAP-EYE | OPHTHALMOLOGY | INTRAVITREAL BEVACIZUMAB | ANATOMICAL OUTCOMES | ANTI-VEGF THERAPY | ENDOTHELIAL GROWTH-FACTOR | Bevacizumab - therapeutic use | Receptors, Vascular Endothelial Growth Factor - therapeutic use | Follow-Up Studies | Intravitreal Injections | Tomography, Optical Coherence | Humans | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Male | Treatment Outcome | Wet Macular Degeneration - physiopathology | Ranibizumab - therapeutic use | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Wet Macular Degeneration - diagnosis | Visual Acuity - drug effects | Wet Macular Degeneration - drug therapy | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Female | Aged | Retrospective Studies | Drug Substitution | Fluorescein Angiography
Original Paper | Wet age-related macular degeneration | Choroidal neovascularization | Switch | Aflibercept | Ranibizumab | Bevacizumab | TACHYPHYLAXIS | PHOTODYNAMIC THERAPY | MACULAR DEGENERATION | DISEASE | TRAP-EYE | OPHTHALMOLOGY | INTRAVITREAL BEVACIZUMAB | ANATOMICAL OUTCOMES | ANTI-VEGF THERAPY | ENDOTHELIAL GROWTH-FACTOR | Bevacizumab - therapeutic use | Receptors, Vascular Endothelial Growth Factor - therapeutic use | Follow-Up Studies | Intravitreal Injections | Tomography, Optical Coherence | Humans | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Male | Treatment Outcome | Wet Macular Degeneration - physiopathology | Ranibizumab - therapeutic use | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Wet Macular Degeneration - diagnosis | Visual Acuity - drug effects | Wet Macular Degeneration - drug therapy | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Female | Aged | Retrospective Studies | Drug Substitution | Fluorescein Angiography
Journal Article
PHYSIOLOGICAL RESEARCH, ISSN 0862-8408, 2009, Volume 58, Issue 6, pp. 835 - 842
Effects of ETB receptor stimulation and its subcellular pathways were evaluated in carbachol pre-contracted rabbit iris sphincter muscles (n=51). ETB...
Sarafotoxin-s6c | ENDOTHELIN RECEPTOR | PHYSIOLOGY | QUANTITATIVE AUTORADIOGRAPHIC VISUALIZATION | MESSENGER-RNA EXPRESSION | SARAFOTOXIN S6C | SMALL-INTESTINE | Muscle fibers | Peptide hormones | CILIARY BODY | Iris | SMOOTH-MUSCLE | NITRIC-OXIDE | PROSTAGLANDIN RECEPTORS | ETB2 | PHOSPHOINOSITIDE TURNOVER | Electric Stimulation | Iris - metabolism | Endothelins - pharmacology | Nitric Oxide Synthase - antagonists & inhibitors | Male | Peptide Fragments - pharmacology | Dose-Response Relationship, Drug | Muscle, Smooth - drug effects | Receptor, Endothelin B - agonists | Piperidines - pharmacology | Iris - drug effects | Rabbits | Endothelin-1 - metabolism | Enzyme Inhibitors - pharmacology | Muscle, Smooth - metabolism | Indomethacin - pharmacology | Peptides - pharmacology | Nitroarginine - pharmacology | Carbachol - pharmacology | Animals | Prostaglandin-Endoperoxide Synthases - metabolism | Receptor, Endothelin A - metabolism | Nitric Oxide Synthase - metabolism | Receptor, Endothelin B - metabolism | Muscle Relaxation - drug effects | In Vitro Techniques | Nitric Oxide - metabolism | Oligopeptides - pharmacology | Prostaglandins - metabolism
Sarafotoxin-s6c | ENDOTHELIN RECEPTOR | PHYSIOLOGY | QUANTITATIVE AUTORADIOGRAPHIC VISUALIZATION | MESSENGER-RNA EXPRESSION | SARAFOTOXIN S6C | SMALL-INTESTINE | Muscle fibers | Peptide hormones | CILIARY BODY | Iris | SMOOTH-MUSCLE | NITRIC-OXIDE | PROSTAGLANDIN RECEPTORS | ETB2 | PHOSPHOINOSITIDE TURNOVER | Electric Stimulation | Iris - metabolism | Endothelins - pharmacology | Nitric Oxide Synthase - antagonists & inhibitors | Male | Peptide Fragments - pharmacology | Dose-Response Relationship, Drug | Muscle, Smooth - drug effects | Receptor, Endothelin B - agonists | Piperidines - pharmacology | Iris - drug effects | Rabbits | Endothelin-1 - metabolism | Enzyme Inhibitors - pharmacology | Muscle, Smooth - metabolism | Indomethacin - pharmacology | Peptides - pharmacology | Nitroarginine - pharmacology | Carbachol - pharmacology | Animals | Prostaglandin-Endoperoxide Synthases - metabolism | Receptor, Endothelin A - metabolism | Nitric Oxide Synthase - metabolism | Receptor, Endothelin B - metabolism | Muscle Relaxation - drug effects | In Vitro Techniques | Nitric Oxide - metabolism | Oligopeptides - pharmacology | Prostaglandins - metabolism
Journal Article
20.
Full Text
WAGNER syndrome: anatomic, functional and genetic characterization of a Portuguese family
Graefe's Archive for Clinical and Experimental Ophthalmology, ISSN 0721-832X, 1/2018, Volume 256, Issue 1, pp. 163 - 171
To report the clinical (anatomic and functional) and genetic findings of Wagner Syndrome (WS) in a Portuguese family.Nine members of the family agreed to be...
Hereditary vitreoretinopathy | Retinal detachment | VCAN | Medicine & Public Health | Ophthalmology | Wagner syndrome | Stickler syndrome | ABNORMALITIES | SITE MUTATION | EXON-2 | EROSIVE VITREORETINOPATHY | SPLICE VARIANTS | FEATURES | REGION | DISEASE | OPHTHALMOLOGY | STICKLER-SYNDROME | CSPG2 GENE | Eye | Medicine, Experimental | Medical research | Medical examination | Surgery | Visual field | Myopia | Electrophysiology | Retina | Electroretinograms | Atrophy | Photography | Color vision | Pedigree | Dystrophy | Deoxyribonucleic acid--DNA
Hereditary vitreoretinopathy | Retinal detachment | VCAN | Medicine & Public Health | Ophthalmology | Wagner syndrome | Stickler syndrome | ABNORMALITIES | SITE MUTATION | EXON-2 | EROSIVE VITREORETINOPATHY | SPLICE VARIANTS | FEATURES | REGION | DISEASE | OPHTHALMOLOGY | STICKLER-SYNDROME | CSPG2 GENE | Eye | Medicine, Experimental | Medical research | Medical examination | Surgery | Visual field | Myopia | Electrophysiology | Retina | Electroretinograms | Atrophy | Photography | Color vision | Pedigree | Dystrophy | Deoxyribonucleic acid--DNA
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.